Start Biochemie MAO-Inhibition Primary Locus Intervention: A novel approach to treating age-associated hormone insufficiency
18.05.2012
Primary Locus Intervention: A novel approach to treating age-associated hormone insufficiency PDF Drucken E-Mail
Biochemie - MAO-Inhibition
Geschrieben von: http://www.ncbi.nlm.nih.gov   
Freitag, den 07. Januar 2011 um 20:53 Uhr

There is consensus among practitioners of age-management/longevity medicine that progressive failure of neuroendocrine function leads to hormone insufficiency, which underlies many of the maladaptive consequences of aging. Accordingly, one of the most commonly employed clinical interventions in aging is balanced hormone replacement therapy (HRT). This approach is often quite effective since many of the structural and functional consequence of aging result at least in part from inadequate endogenous hormone supply and/or imbalance of multiple hormone actions upon the body. However, while HRT is effective in opposing many of the more obvious degenerative effects of aging on body composition and function it does little to treat the pathophysiological factors underlying neuroendocrine decline. In fact, HRT may actually accelerate senescence of neuroendocrine elements within the brain and pituitary gland.

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686323/

 
SHOPS
Heilkräuter
   
     
Nahrungsergänzungen

pilz1
Shop Nahrungsergänzungsmittel

 
Suche

Erweiterte Suche
Warenkorb
0 Produkte - 0.00 EUR
Zum Warenkorb
Shop Login



NN Biochemie
MG Biochemie
Wer ist online
Wir haben 147 Gäste online